50 employees
VitaPath Genetics develops DNA tests to help individuals reduce the risk of serious and life-threatening diseases.
2009
$6M
from 4 investors over 4 rounds
VitaPath Genetics raised $4.7M on April 1, 2012
Investors: Mohr Davidow Ventures and XSeed Capital
VitaPath Genetics raised $6M on November 2, 2009
Investors: XSeed Capital and Mohr Davidow Ventures